Surgical Removal of the Primary Tumor Increases Overall Survival in Patients With Metastatic Breast Cancer: Analysis of the 1988–2003 SEER Data

By Gnerlich Jennifer   Jeffe Donna   Deshpande Anjali   Beers Courtney   Zander Christina   Margenthaler Julie  

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2187-2194

Springer Publishing Company

Access to resources Recommend Favorite

Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

By Nakamura Seigo  

Breast Cancer, Vol. 17, Iss. 3, 2010-07 ,pp. : 199-204

Springer Publishing Company

Access to resources Recommend Favorite

Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials

By Blum Joanne   Kohles Joseph   McKenna Edward   Scotto Nana   Hu Sylvia   Odom Dawn   Kaye James   Glück Stefan  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 431-439

Springer Publishing Company

Access to resources Recommend Favorite

Metastatic Breast Cancer: Overall Survival Related to Successive Chemotherapies. What Do We Gain After the Third Line?

By Tacca Olivier   LeHeurteur Marianne   Durando Xavier   Mouret-Reynier Marie-Ange   Abrial Catherine   Thivat Emilie   Bayet-Robert Mathilde   Penault-Llorca Frederique   Chollet Phillippe  

Cancer Investigation, Vol. 27, Iss. 1, 2009-01 ,pp. : 81-85

Informa Healthcare

Access to resources Recommend Favorite

Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

By Artac Mehmet  

Breast Cancer, Vol. 20, Iss. 2, 2013-04 ,pp. : 174-180

Springer Publishing Company

Access to resources Recommend Favorite